We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,570.00
Bid: 2,572.00
Ask: 2,574.00
Change: 16.00 (0.63%)
Spread: 2.00 (0.078%)
Open: 2,564.00
High: 2,576.00
Low: 2,546.00
Prev. Close: 2,554.00
CCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of equity and total voting rights

3 Sep 2018 12:26

RNS Number : 5955Z
Coca-Cola HBC AG
03 September 2018
 

FOR IMMEDIATE RELEASE

Coca-Cola HBC AG

Issue of equity and total voting rights

 

Zug, Switzerland - 3 September 2018 - Coca-Cola HBC AG ("Coca-Cola HBC") today announces in respect of the month ended 31 August 2018, the issue of 115,000 shares of CHF 6.70 each fully paid ("Ordinary Shares"), following the exercise of options granted under Coca-Cola HBC's share option plan.

 

Such Ordinary Shares were also admitted to the Official List of the UK Listing Authority and to trading on the London Stock Exchange's main market for listed securities under Coca-Cola HBC's block listing facility. Following this issue, Coca-Cola HBC has the ability to admit a further 28,375,267 Ordinary Shares under its block listing facility.

 

As at 31 August 2018, Coca-Cola HBC's issued share capital consisted of 371,773,229 Ordinary Shares, of which 14,925 Ordinary shares are held by Coca-Cola HBC AG and 3,430,135 shares are held by its subsidiary, Coca-Cola HBC Services MEPE, in treasury. Accordingly, as at 31 August 2018, the total number of voting rights in Coca-Cola HBC is 368,328,169 for the purposes of the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority ("DTRs").

 

Shareholders may use the above total voting rights figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of Coca-Cola HBC under the DTRs.

 

This announcement is made in accordance with DTR 5.6.1.

 

Enquiries

Coca‑Cola HBC Group

Basak Kotler

Investor Relations Director

Tel: +44 20 37 444 231

 basak.kotler@cchellenic.com

 

 

Joanna Kennedy

Investor Relations Manager

Tel: +44 20 37 444 230

 joanna.kennedy@cchellenic.com

 

 

Vasso Aliferi

Investor Relations Manager

Tel: +41 44 835 9274

 vasso.aliferi@cchellenic.com

 

About Coca‑Cola HBC

Coca-Cola HBC is a leading bottler of The Coca-Cola Company with a sales volume of more than 2 billion unit cases. It has a broad geographic footprint with operations in 28 countries serving a population of approximately 600 million people. Coca-Cola HBC offers a diverse range of non-alcoholic ready to drink beverages in the sparkling, juice, water, sport, energy, tea and coffee categories. Coca-Cola HBC is committed to promoting sustainable development in order to create value for its business and for society. This includes providing products that meet the beverage needs of consumers, fostering an open and inclusive work environment, conducting its business in ways that protect and preserve the environment and contribute to the socio-economic development of the local communities. Coca-Cola HBC is ranked beverage industry leader in the Dow Jones Sustainability World and Europe Indices, and is also included in the FTSE4Good Index.

 

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and its shares are listed on the Athens Exchange (ATHEX: EEE). For more information, please visit http://www.coca-colahellenic.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFXLFBVKFLBBZ
Date   Source Headline
15th Nov 20233:11 pmRNSPost 2023 AGM Shareholder Engagement
9th Nov 20233:20 pmRNSDirector/PDMR Shareholding
1st Nov 20234:30 pmRNSCCH Completes the acquisition of Finlandia Vodka
1st Nov 20231:31 pmRNSBlock listing Interim Review
31st Oct 20237:00 amRNSStrong growth driving further value creation
18th Oct 20233:42 pmRNSDirector/PDMR Shareholding
5th Oct 202310:21 amRNSNotice of Results
2nd Oct 20239:23 amRNSIssue of equity and total voting rights
21st Sep 202311:01 amRNSDirector/PDMR Shareholding
19th Sep 20231:02 pmRNSDirector/PDMR Shareholding
14th Sep 20232:04 pmRNSDirector/PDMR Shareholding
1st Sep 202312:14 pmRNSDirector/PDMR Shareholding
1st Sep 202311:51 amRNSDirector/PDMR Shareholding
18th Aug 202312:16 pmRNSDirector/PDMR Shareholding
18th Jul 20231:06 pmRNSDirector/PDMR Shareholding
11th Jul 20233:53 pmRNSNotice of Results
7th Jul 20237:00 amRNSTRADING UPDATE
3rd Jul 20239:12 amRNSDirector/PDMR Shareholding
3rd Jul 20238:32 amRNSIssue of equity and total voting rights
23rd Jun 20234:04 pmRNSDirector/PDMR Shareholding
21st Jun 202311:05 amRNSDirector/PDMR Shareholding
21st Jun 202310:46 amRNSDirector/PDMR Shareholding
19th Jun 20233:06 pmRNSDirector/PDMR Shareholding
19th Jun 20237:00 amRNSCCH to acquire Finlandia Vodka from Brown-Forman
1st Jun 202310:07 amRNSIssue of equity and total voting rights
25th May 20237:00 amRNSCoca-Cola HBC Investor Day
18th May 20232:50 pmRNSDirector/PDMR Shareholding
18th May 20232:46 pmRNSDirector/PDMR Shareholding
17th May 20233:44 pmRNSCCH - Board Committees Composition
17th May 20233:37 pmRNSResult of AGM
4th May 20232:43 pmRNSAthens Exchange trading date of ordinary shares
3rd May 20237:00 amRNSStrategic progress driving strong revenue growth
2nd May 202311:23 amRNSBlock listing Interim Review
2nd May 202310:38 amRNSIssue of equity and total voting rights
24th Apr 20232:03 pmRNSNotice of Results-NEW TIME for the analysts call
18th Apr 20232:46 pmRNSDirector/PDMR Shareholding
13th Apr 20238:41 amRNSNotice of AGM
3rd Apr 20233:14 pmRNSNotice of Results
3rd Apr 20232:52 pmRNSIssue of equity and total voting rights
31st Mar 20232:54 pmRNSDirector/PDMR Shareholding
31st Mar 202312:30 pmRNSDirector/PDMR Shareholding
31st Mar 202312:22 pmRNSDirector/PDMR Shareholding
31st Mar 20239:11 amRNSDirector/PDMR Shareholding
31st Mar 20238:52 amRNSDirector/PDMR Shareholding
24th Mar 20231:48 pmRNSDirector/PDMR Shareholding
23rd Mar 20231:10 pmRNSDirector/PDMR Shareholding
21st Mar 20239:48 amRNSDirector/PDMR Shareholding
21st Mar 20239:20 amRNSDirector/PDMR Shareholding
20th Mar 20234:11 pmRNSAnnual Financial Report
17th Mar 20232:39 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.